Arch Therapeutics (OTCMKTS:ARTH) vs. Titan Medical (NASDAQ:TMDIF) Financial Survey

Insider and Institutional Ownership

6.9% of Arch Therapeutics shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 4.5% of Arch Therapeutics shares are held by insiders. Comparatively, 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Arch Therapeutics and Titan Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arch Therapeutics	$80,000.00	0.00	-$6.98 million	N/A	N/A
Titan Medical	$17.63 million	2.34	$6.95 million	$0.05	7.23

Titan Medical has higher revenue and earnings than Arch Therapeutics.

Profitability

This table compares Arch Therapeutics and Titan Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Arch Therapeutics	-8,257.70%	N/A	-730.22%
Titan Medical	N/A	-82.31%	-51.47%

Volatility and Risk

Arch Therapeutics has a beta of 4.02, indicating that its stock price is 302% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.

About Arch Therapeutics

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.